Welcome to Ptcbio.com - PTC Therapeutics | Pioneers in Rare Disease Treatments

ptcbio.com

Description: PTC Bio. Translating Science. Transforming Lives..

Google PR 5

Trustworthiness Good
Avg. Daily Visitors 757

Child Safety Unknown
Avg. Daily Pageviews 1 514

Privacy Good

PTC Therapeutics | Pioneers in Rare Disease Treatments

Ptcbio.com: get to the top rated PTC Bio pages and content popular with USA-based Ptcbio.com users or check the following digest to find out more. Ptcbio.com is a malware-free website without age restrictions, so you can safely browse it. It seems that PTC Bio team are just starting to conquer the social media and they have already achieved a promising result — 214 user activities so far (LinkedIn dominates with around 95% of all user reactions). Ptcbio.com is hosted with Pantheon in United States. PTC Bio traffic is estimated at around 22.7K visits per month.

Visit ptcbio.com

Domain info

Location:	United States
Registrant:	Domain Administrator (PTC Therapeutics)
Hosted by:	Pantheon
Registrar:	CSC Corporate Domains, Inc.
Subnetworks:	23.185.0.4

Alexa's Traffic Estimates & Trends

Traffic Rank:	182 338
Month Average Daily Reach:	0.000076	-2.6%
Month Average Daily Pageviews:	0.000003	+ 47.2%

More details from Alexa

Social Media Activities

Facebook likes: -
Twitter mentions: -
Google pluses: 9
LinkedIn mentions: 204
Pinterest pins: -
StumbleUpon views: 1

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

ir.ptcbio.com

Whois

Expand

Ptcbio.com popular pages to visit

PTC Therapeutics | Ataluren (Translarna™) Find out more about Translarna (ataluren), the first treatment approved for the underlying cause of Duchenne muscular dystrophy.

PTC Therapeutics | Pioneers in Rare Disease Treatments PTC Therapeutics pioneers pharmaceutical science to transform lives and treat rare diseases, like Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Huntington's Disease, Leukemia, and more.

PTC Therapeutics | ACT CF Clinical Trial FAQ Get your questions answered about PTC's ongoing ataluren clinical trials in patients with nonsense mutation genetic disorders.